Skip to main content

Animal Models in Genitourinary Malignancies

  • Chapter
Book cover Urological Oncology

Abstract

In vitro cell culture techniques facilitate cultivation of human- and animal-origin cells for prolonged periods of time. Cell lines, harvested from primary or metastatic sites, maintain some of the phenotypical characteristics of the tumor of origin. However, establishing cell lines from early or premalignant disease, such as primary cultures, is more difficult. Cells can be immortalized inadvertently by exposure to environmental carcinogens or by repeated passage, transfection with viral or human oncogenes, and chemical or radiation exposure. Cell lines are vulnerable to significant interspecies and intercell-type contamination.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Navone NM, Logothetis CJ, von Eschenbach AC, Troncoso P. Model systems of prostate cancer: uses and limitations. Cancer Metastasis Rev 1998;17:361–371.

    Article  PubMed  Google Scholar 

  2. Dinney CP, McConkey DJ, Millikan RE, et al. Focus on bladder cancer. Cancer Cell 2004;6:111–116.

    Article  CAS  PubMed  Google Scholar 

  3. Brandau S, Böhle A. Review of bladder cancer: I. Molecular and genetic basis of carcinogenesis. Eur Urol 2001;39:491–497.

    Article  CAS  PubMed  Google Scholar 

  4. Hillman GG, Droz JP, Haas GP. Experimental animal models for the study of therapeutic approaches in renal cell carcinoma. In Vivo 1994;8:77–80.

    CAS  PubMed  Google Scholar 

  5. Yeung RS, Xiao GH, Jin G, et al. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci USA 1994;91:11413–11416.

    Article  CAS  PubMed  Google Scholar 

  6. Okimoto K, Sakurai J, Kobayashi T, et al. A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer. Proc Natl Acad Sci USA 2004;101:2023–2027.

    Article  CAS  PubMed  Google Scholar 

  7. Montironi R, Mazzucchelli R, Scarpelli M. Molecular techniques and prostate cancer diagnostic. Eur Urol 2003;44:390–400.

    Article  CAS  PubMed  Google Scholar 

  8. Petricoin EF, Ornstein DK, Liotta LA. Clinical proteomics: applications for prostate cancer biomarker discovery and detection. Urol Oncol 2004;22:322–328.

    CAS  PubMed  Google Scholar 

  9. Sanchez-Carbayo M. Recent advances in bladder cancer diagnostics. Clin Biochem 2004;37:562–571.

    Article  CAS  PubMed  Google Scholar 

  10. Lin X, Tascilar M, Lee W-H, et al. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol 2001;159:1815–1826.

    CAS  PubMed  Google Scholar 

  11. Sarosdy MF, Schellhammer P, Bokinsky G, et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 2002; 168:1950–1954.

    Article  CAS  PubMed  Google Scholar 

  12. Lemoine NR, ed. Understanding Gene Therapy, 1st ed. Oxford: Bios, 1999.

    Google Scholar 

  13. Foley R, Lawler M, Hollywood D. Gene-based therapy in prostate cancer. Lancet Oncol 2004;5:469–479.

    Article  CAS  PubMed  Google Scholar 

  14. Mazhar D, Waxman J. Gene therapy for prostate cancer. BJU Int 2004;93:465–469.

    Article  CAS  PubMed  Google Scholar 

  15. Pagliaro LC. Gene therapy for bladder cancer. World J Urol 2000;18:148–151.

    Article  CAS  PubMed  Google Scholar 

  16. Gore M, Riches P, eds. Immunotherapy in Cancer, 1st ed. Chichester: Wiley, 1996.

    Google Scholar 

  17. Fuchs EJ, Matzinger P. Is cancer dangerous to the immune system? Semin Immunol 1996;8:271–280.

    Article  CAS  PubMed  Google Scholar 

  18. Igney FH, Krammer PH. Immune escape of tumors: apoptosis resistance and tumor counterattack. J Leukoc Biol 2002;71:907–920.

    CAS  PubMed  Google Scholar 

  19. Bohle A, Brandau S. Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. J Urol 2003:170:964–969.

    Article  PubMed  Google Scholar 

  20. Mancuso A, Sternberg CN. What’s new in the treatment of metastatic kidney cancer? BJUInt 2005;95:1171–1180.

    Article  CAS  Google Scholar 

  21. Shiraishi T, Muneyuki T, Fukutome K, et al. Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations. Anticancer Res 1998;18:2789–2792.

    CAS  PubMed  Google Scholar 

  22. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005;16:83–95.

    Article  PubMed  Google Scholar 

  23. John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res 2005;65:5470–5409.

    Article  CAS  PubMed  Google Scholar 

  24. Coetzee GA, Ross RK. Re: prostate cancer and the androgen receptor. J Natl Cancer Inst 1994;86:872–873.

    Article  CAS  PubMed  Google Scholar 

  25. Madeb R, Messing EM. Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 2004;22:86–92.

    PubMed  Google Scholar 

  26. Anisimov VN. The relationship between aging and carcinogenesis: a critical appraisal. Crit Rev Oncol Hematol 2003;45:277–304.

    Article  PubMed  Google Scholar 

  27. Balducci L, Ershler WB. Cancer and ageing: a nexus at several levels. Nat Rev Cancer 2005;5:655–662.

    Article  CAS  PubMed  Google Scholar 

  28. Serrano M, Blasco MA. Putting the stress on senescence. Curr Opin Cell Biol 2001; 13:748–753.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Rajan, P., Leung, H.Y. (2008). Animal Models in Genitourinary Malignancies. In: Nargund, V.H., Raghavan, D., Sandler, H.M. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-1-84628-738-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-738-1_2

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-387-1

  • Online ISBN: 978-1-84628-738-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics